Original articleAnti-tubercular agents. Part 5: Synthesis and biological evaluation of benzothiadiazine 1,1-dioxide based congeners

Add time:08/28/2019    Source:sciencedirect.com

In an effort to discover new and effective chemotherapeutic agents from this laboratory for the treatment of tuberculosis, here in we describe the synthesis and biological evaluation of a series of novel benzothiadiazine 1,1-dioxide (BTD) based congeners by using rifampicin, streptomycin; ciprofloxacin and amphotericin as positive controls. Further, to understand structural requirements for exploring the structure activity relationship of BTDs, cytotoxicity and in vivo study of recently reported potent molecule 4 (MIC = 1 μg/mL) is also discussed.

We also recommend Trading Suppliers and Manufacturers of [[(6-Chloro-2H-1,2,4-benzothiadiazine 1,1-dioxide)-3-yl]thio]acetic acid (cas 114260-70-7). Pls Click Website Link as below: cas 114260-70-7 suppliers

Prev:Study on kinetics and mechanism of dinuclear metal zinc(II) complexes in promoting the hydrolysis of 2-hydroxy-propyl-p-nitrophenyl phosphate (HPNP)
Next:Synthesis and pharmacological evaluation of a second generation of pyridothiadiazine 1,1-dioxides acting as AMPA potentiators)